文献速递肝胆胰外科

肝内胆管癌微创切除选择标准:倾向评分匹配分析

Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.
PubMed 文献 · Surg Endosc · 2021-11-08

基于美国国家癌症数据库2010至2016年988例肝内胆管癌肝切除患者,经1:1倾向评分匹配后比较微创与开腹手术。微创组30天再入院率和切缘阳性率更低、住院时间更短,但淋巴结检出数更少,且总生存更差(HR 2.454)。作者认为肿瘤>4 cm需大范围肝切除时应选择性采用微创。

要点

  • 微创组淋巴结检出数低于开腹组(1.52 vs 2.07,P=0.001)。
  • 微创组总生存劣于开腹组(HR 2.454,P=0.001)。
  • 生存差异取决于大范围肝切除、肿瘤>4 cm或切缘阴性。

核心结论

  • 肝内胆管癌微创切除与开腹相比淋巴结清扫和生存更差,尤其肿瘤>4 cm需大范围肝切除者。
  • 作者认为微创大范围肝切除应选择性开展,且术者需能完成适当的淋巴结清扫。

研究设计与样本

  • 回顾性倾向评分匹配分析,数据来自美国国家癌症数据库,纳入2010至2016年肝内胆管癌肝切除患者。
  • 共988例,微创140例(14.2%),开腹848例(85.8%);1:1匹配后微创和开腹各115例,c-index为0.733。

主要发现

  • 微创组30天非计划再入院率更低(OR 0.075,P=0.014)。
  • 微创组切缘阳性率更低(OR 0.361,P=0.011),住院时间更短(OR 0.941,P=0.026)。
  • 微创组淋巴结检出数低于开腹组(1.52 vs 2.07,P=0.001)。
  • 30天和90天死亡率无差异。
  • 多因素分析显示微创与更差的总生存相关(HR 2.454,P=0.001)。

临床怎么用

  • 作者认为,肝内胆管癌微创大范围肝切除应选择性开展,且术者需能完成适当的淋巴结清扫。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While minimally invasive liver resection (MILR) vs. open approach (OLR) has been shown to be safe, the perioperative and oncologic safety for intrahepatic cholangiocarcinoma (ICC) specifically, necessitating often complex hepatectomy and extended lymphadenectomy, remains ill-defined. METHODS: The National Cancer Database was queried for patients with ICC undergoing liver resection from 2010 to 2016. After 1:1 Propensity Score Matching (PSM), Kruskal-Wallis and χ2 tests were applied to compare short-term outcomes. Kaplan-Meier survival analyses and Cox multivariable regression were performed. RESULTS: 988 patients met inclusion criteria: 140 (14.2%) MILR and 848 (85.8%) OLR resulting in 115 patients MILR and OLR after 1:1 PSM with c-index of 0.733. MILR had lower unplanned 30-day readmission [OR 0.075, P = 0.014] and positive margin rates [OR 0.361, P = 0.011] and shorter hospital length of stay (LOS) [OR 0.941, P = 0.026], but worse lymph node yield [1.52 vs 2.07, P = 0.001]. No difference was found for 30/90-day mortality. Moreover, multivariate analysis revealed that MILR was associated with poorer overall survival compared to OLR [HR 2.454, P = 0.001]. Subgroup analysis revealed that survival differences from approach were dependent on major hepatectomy, tumor size > 4 cm, or negative margins. CONCLUSION: MILR vs. OLR is associated with worse lymphadenectomy and survival in patients with ICC greater than 4 cm requiring major hepatectomy. Hence, MILR major hepatectomy for ICC should only be approached selectively and if surgeons are able to perform an appropriate lymphadenectomy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Salehi O, Kazakova V, Vega EA, et al. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database. Surg Endosc. 2021. PMID: 34750709. doi:10.1007/s00464-021-08842-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。